CJC 1295 (No DAC)

From $60.98

CJC-1295 (No DAC) is a synthetic growth hormone-releasing hormone (GHRH) analogue investigated in laboratory research involving endocrine signaling, pituitary physiology, peptide biology, and molecular endocrinology. Manufactured in the USA and third-party tested, it is supplied exclusively for laboratory and scientific research.

Description

Research Overview

CJC-1295 (No DAC) is a synthetic analogue of growth hormone-releasing hormone (GHRH) developed for laboratory investigations involving endocrine physiology and peptide-mediated signaling. Unlike the DAC-modified version of CJC-1295, the No DAC formulation does not include a Drug Affinity Complex, making it an important research tool for scientists interested in studying the biological characteristics of the peptide without prolonged circulating activity.

Researchers continue to investigate CJC-1295 (No DAC) to better understand GHRH receptor biology, pituitary communication, and the mechanisms that regulate endogenous growth hormone signaling. Because it closely resembles naturally occurring GHRH, it provides laboratories with a valuable model for examining endocrine pathways under controlled experimental conditions.

As peptide endocrinology continues to advance, CJC-1295 (No DAC) remains a widely investigated compound in studies involving hormonal regulation, receptor biology, and molecular physiology.


Why Researchers Study CJC-1295 (No DAC)

Researchers investigate CJC-1295 (No DAC) because it provides an opportunity to examine GHRH receptor signaling without the extended pharmacokinetic profile associated with DAC-modified formulations. This distinction makes it especially useful for laboratory models that require investigation of shorter-duration peptide activity.

Its structural similarity to endogenous GHRH and its defined receptor pathway continue to make CJC-1295 (No DAC) an important investigational peptide within endocrine and peptide biology research.


Mechanism of Interest

Current laboratory investigations examine CJC-1295 (No DAC) for its involvement in biological pathways including:

  • Growth hormone-releasing hormone (GHRH) signaling
  • Pituitary physiology
  • Endocrine communication
  • Hormonal regulation
  • Peptide-mediated signaling
  • Molecular endocrinology
  • Cellular signaling
  • Experimental peptide biology

These mechanisms remain active areas of scientific investigation within laboratory and preclinical research settings.


Research Applications

CJC-1295 (No DAC) is commonly utilized in laboratory investigations involving:

  • Endocrine research
  • GHRH receptor biology
  • Pituitary physiology
  • Molecular endocrinology
  • Peptide pharmacology
  • Cellular signaling
  • Experimental physiology
  • Hormonal regulation studies

These applications are intended exclusively for laboratory and scientific investigation.


Product Specifications

  • Product: CJC-1295 (No DAC)
  • Form: Lyophilized Peptide
  • Strength: Refer to selected product option
  • Available Options: Single Vial or Research Kit
  • Manufactured In: United States
  • Quality Testing: Third-Party Tested
  • Storage: Refrigerate upon receipt. For extended laboratory storage, freezing is recommended.

Storage & Handling

Store CJC-1295 (No DAC) under refrigerated conditions immediately upon receipt. For long-term laboratory storage, freezing is recommended according to established laboratory protocols. Researchers should minimize repeated freeze-thaw cycles and follow appropriate laboratory handling procedures to help preserve peptide stability throughout experimental use.


Frequently Asked Questions

What is CJC-1295 (No DAC)?

CJC-1295 (No DAC) is a synthetic analogue of growth hormone-releasing hormone (GHRH) commonly investigated in laboratory research involving endocrine signaling and pituitary physiology.

What does “No DAC” mean?

“No DAC” indicates that this formulation does not contain the Drug Affinity Complex used in certain modified versions of CJC-1295. Researchers often distinguish between these formulations based on their intended experimental design and pharmacokinetic characteristics.

How is CJC-1295 (No DAC) different from Tesamorelin?

Both compounds are investigated as GHRH analogues, but they differ in molecular structure and research applications. Scientists often compare their biological characteristics within endocrine research models.

Is this product intended for human use?

No. CJC-1295 (No DAC) supplied by 4LD Research is intended exclusively for laboratory and scientific research. It is not intended for human consumption, veterinary use, therapeutic applications, or diagnostic procedures.


Related Products

Researchers interested in CJC-1295 (No DAC) may also explore:


Research Use Disclaimer

For Research Use Only.

Products sold by 4LD Research are intended exclusively for laboratory and scientific research by qualified professionals. They are not intended for human consumption, veterinary use, therapeutic procedures, or diagnostic applications. Researchers are responsible for complying with all applicable laws, regulations, and institutional guidelines governing the handling and use of research materials.

Additional information

Package

10 Vial Kit, Single Vial

Size

10mg, 5mg